Ascentage Pharma has executed an Exclusive Option to License Global Rights to Olverembatinib worldwide other than China and a few other areas
This clearance is a foundational step in Roche's commitment to enable routine clinical diagnosis with its digital pathology solutions
India's healthcare sector anticipates telemedicine reaching US$ 5.4 billion by 2025, with AI growing at 45% by 2024 and Healthtech jobs increasing 15-20%
Abdel has held leadership positions at Bayer, Merck, Catalent, Lonza, and KBI Biopharma,
Over 13 million US adults aged 50-59 years have a medical condition that increases their risk of severe RSV outcomes
Higher efficacy was observed in mRNA-1283 compared to Spikevax in adults 18 years of age and older
Approval based on results from T2NOW, one of the largest paediatric type-2 diabetes Phase III trials to date
HaystackAnalytics is engaged in the business of developing genomic analysis software
The companies have initiated Phase 3 studies in patients with high-risk melanoma and non-small cell lung cancer
mRESVIA is Moderna's second approved product and the only RSV vaccine available in single-dose pre-filled syringes
Subscribe To Our Newsletter & Stay Updated
